Search Results - "Holowiecki, J"

Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells by Smagur, A., Mitrus, I., Giebel, S., Sadus-Wojciechowska, M., Najda, J., Kruzel, T., Czerw, T., Gliwinska, J., Prokop, M., Glowala-Kosinska, M., Chwieduk, A., Holowiecki, J.

“…Background and Objectives  The procedure of autologous hematopoietic stem/progenitor cell transplantation requires cryopreservation. Addition of DMSO is…”
Get full text

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning by Casper, J, Holowiecki, J, Trenschel, R, Wandt, H, Schaefer-Eckart, K, Ruutu, T, Volin, L, Einsele, H, Stuhler, G, Uharek, L, Blau, I, Bornhaeuser, M, Zander, A R, Larsson, K, Markiewicz, M, Giebel, S, Kruzel, T, Mylius, H A, Baumgart, J, Pichlmeier, U, Freund, M, Beelen, D W

“…An alternative reduced-toxicity conditioning regimen for allogeneic transplantation, based on treosulfan and fludarabine, has recently been identified. The…”
Get full text

Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation by Smagur, A., Mitrus, I., Ciomber, A., Panczyniak, K., Fidyk, W., Sadus-Wojciechowska, M., Holowiecki, J., Giebel, S.

“…Background and Objectives Cryopreservation of peripheral blood hematopoietic progenitor/stem cells (PBPCs) requires the addition of cryoprotectant such as…”
Get full text

E02 Autologous haematopoetic cell transplantation for acute myeloblastic leukaemia by Holowiecki, J

Get full text

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial by RUUTU, Tapani, VOLIN, Liisa, BLAU, Igor W, KIENAST, Joachim, STELLJES, Matthias, LARSSON, Kajsa, ZANDER, Axel R, GRAMATZKI, Martin, REPP, Roland, EINSELE, Hermann, STUHLER, Gernot, BAUMGART, Joachim, BEELEN, Dietrich W, MYLIUS, Heidrun A, PICHLMEIER, Uwe, FREUND, Mathias, CASPER, Jochen, TRENSCHEL, Rudolf, FINKE, Juergen, SCHNITZLER, Marc, HOLOWIECKI, Jerzy, GIEBEL, Sebastian, MARKIEWICZ, Miroslaw, UHAREK, Lutz

“…An alternative reduced-toxicity conditioning regimen for allogeneic transplantation, based on treosulfan and fludarabine, has recently been identified. The…”
Get full text

Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers by Giebel, S, Kruzel, T, Czerw, T, Sadus-Wojciechowska, M, Najda, J, Chmielowska, E, Grosicki, S, Jurczyszyn, A, Pasiarski, M, Nowara, E, Glowala-Kosinka, M, Chwieduk, A, Mitrus, I, Smagur, A, Holowiecki, J

“…The optimal protocol for mobilization of hematopoietic stem cells in patients with lymphoid malignancies has not been determined so far. We retrospectively…”
Get full text

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL by Giebel, S, Stella-Holowiecka, B, Krawczyk-Kulis, M, Gökbuget, N, Hoelzer, D, Doubek, M, Mayer, J, Piatkowska-Jakubas, B, Skotnicki, A B, Dombret, H, Ribera, J M, Piccaluga, P P, Czerw, T, Kyrcz-Krzemien, S, Holowiecki, J

“…The role of autologous hematopoietic SCT (autoHSCT) in the treatment of high-risk (HR) adult ALL is controversial. In this study, we retrospectively analyzed…”
Get full text

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant by NASILOWSKA-ADAMSKA, B, RZEPECKI, P, DUDA, D, SZYDLO, R, HALABURDA, K, SZCZEPINSKI, A, LANGE, A, HELLMAN, A, ROBAK, T, SKOTNICKI, A, JEDRZEJCZAK, W. W, WALEWSKI, J, MANKO, J, HOLOWIECKI, J, KOMARNICKI, M, DMOSZYNSKA, A, WARZOCHA, K, MARIANSKA, B, CZYZ, A, MARKIEWICZ, M, FEDEROWICZ, I, TOMASZEWSKA, A, PIATKOWSKA-JAKUBAS, B, WRZESIEN-KUS, A, BIENIASZEWSKA, M

“…In this multicenter study, we assessed the use of palifermin (recombinant human-keratinocyte growth factor 1) in the prevention of oral mucositis (OM) and…”
Get full text

Association of KIR2DS4 and its variant KIR1D with leukemia by Giebel, S, Nowak, I, Wojnar, J, Krawczyk-Kulis, M, Holowiecki, J, Kyrcz-Krzemien, S, Kusnierczyk, P

Get full text

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study by HOLOWIECKI, J, GROSICKI, S, ZDZIARSKA, B, DMOSZYNSKA, A, MARIANSKA, B, PLUTA, A, ZAWILSKA, K, KOMARNICKI, M, KLOCZKO, J, SULEK, K, HAUS, O, STELLA-HOLOWIECKA, B, ROBAK, T, BARAN, W, JAKUBAS, B, PALUSZEWSKA, M, WIERZBOWSKA, A, KIELBINSKI, M, JAGODA, K, KYRCZ-KRZEMIEN, S, GIEBEL, S, HELLMANN, A, SKOTNICKI, A, JEDRZEJCZAK, W. W, KONOPKA, L, KULICZKOWSKI, K

“…To assess the efficacy of an original DAC-7 regimen: daunorubicine (DNR) 60 mg/m2/day, days 1-3; cytarabine (AraC) 200 mg/m2/day, days 1-7; cladribine (2-CdA)…”
Get full text

Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation by Helbig, G, Stella-Holowiecka, B, Majewski, M, Lewandowska, M, Holowiecki, J

“…The JAK2 V617F point mutation is very rare in hypereosinophilic syndrome and/or chronic eosinophilic leukemia. Here we report on a patient with chronic…”
Get full text

Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT by Giebel, S, Dziaczkowska, J, Czerw, T, Wojnar, J, Krawczyk-Kulis, M, Nowak, I, Holowiecka, A, Segatti, A, Kyrcz-Krzemien, S, Kusnierczyk, P, Holowiecki, J

“…Alloreactivity of natural killer (NK) cells contributes to the GVL reaction after allogeneic hematopoietic SCT (allo-HSCT). However, various procedure-related…”
Get full text

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients by Czyż, J., Dziadziuszko, R., Knopińska-Postuszuy, W., Hellmann, A., Kachel, Ł., Hołowiecki, J., Goździk, J., Hansz, J., Avigdor, A., Nagler, A., Osowiecki, M., Walewski, J., Mensah, P., Jurczak, W., Skotnicki, A., Sędzimirska, M., Lange, A., Sawicki, W., Sułek, K., Wach, M., Dmoszyńska, A., Kuś, A., Robak, T., Warzocha, K.

“…Background: The reported probability of survival of patients with Hodgkin's disease (HD) following high-dose chemotherapy with autologous stem cell…”
Get full text

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients by ROBAK, T, BLONSKI, J. Z, TOMASZEWSKA, A, HELLMANN, A, LEWANDOWSKI, K, KULICZKOWSKI, K, POTOCZEK, S, ZDZIARSKA, B, HANSZ, J, KROLL, R, KOMARNICKI, M, HOŁOWIECKI, J, KASZNICKI, M, GRIEB, P, KONOPKA, L, CEGLAREK, B, DMOSZYNSK, A, SOROKA-WOJTASZKO, M, SKOTNICKI, A. B, NOWAK, W, DWILEWICZ-TROJACZEK, J

“…Between January 1992 and January 1999, we treated 378 B‐chronic lymphocytic leukaemia (CLL) patients with cladribine (2‐CdA), and 255 of the patients were also…”
Get full text

Beta-2-Microglobulin Level Predicts Outcome Following Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma by Stella-Holowiecka, B, Czerw, T, Holowiecka-Goral, A, Giebel, S, Wojnar, J, Holowiecki, J

“…Abstract Despite the widespread use of high-dose therapy combined with autologous hematopoietic stem cell transplantation (autoHSCT), the outcomes of multiple…”
Get full text

Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT ESH Outreach Programme by Wachowiak, J, Labopin, M, Miano, M, Chybicka, A, Stary, J, Sterba, J, Masszi, T, Labar, B, Maschan, A, Kowalczyk, J R, Lange, A, Holowiecki, J, Kalman, N, Afanassiev, B V, Dini, G

“…The paediatric population of 19 eastern European countries amounts to approximately 80 million children. Between 1985 and 2004, the number of centres…”
Get full text

Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing by Giebel, S, Giorgiani, G, Martinetti, M, Zecca, M, Maccario, R, Salvaneschi, L, Holowiecki, J, Locatelli, F

“…We evaluated the outcome of 63 children given haematopoietic stem cell transplantation from unrelated donors (URD-HSCT) prospectively selected using DNA…”
Get full text

Prediction of Nonrelapse Mortality for Patients Surviving 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation by Wojnar, J, Giebel, S, Holowiecka-Goral, A, Markiewicz, M, Wylezol, I, Kopera, M, Krawczyk-Kulis, M, Holowiecki, J

“…Abstract Background Patients who survive 100 days after allogeneic hematopoietic stem cell transplantation (alloHSCT) are at risk for chronic graft-versus-host…”
Get full text

Impact of Activating Killer Immunoglobulin-like Receptor Genotype on Outcome of Unrelated Donor–Hematopoietic Cell Transplantation by Giebel, S., Nowak, I., Wojnar, J., Markiewicz, M., Dziaczkowska, J., Wylezol, I., Krawczyk-Kulis, M., Bloch, R., Kusnierczyk, P., Holowiecki, J.

“…In a previous study we demonstrated that incompatibility regarding ligands for inhibitory killer immunoglobulin-like receptors (KIRs) is associated with a…”
Get full text

Interferon {alpha} induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation by Helbig, G, Stella-Holowiecka, B, Majewski, M, Lewandowska, M, Holowiecki, J

“…1 Departament of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland; 2 Institute of Hematology and Transfusion…”
Get full text